Evidence map›Paper›PMID 41544177›Full record

ArticlePLoS pathogens2026

Multifaceted B cell response to transient HIV viremia in elite controllers.

Luke Muir, Ondrej Suchanek, Peter Thomas, Sarah A Griffith, Emma Touizer, Chloe Rees-Spear, Robert Krause, Masahiro Yoshida, Christopher L Pinder, Rutuja Patil and 8 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Luke MuirDivision of Infection and Immunity, Institute for Immunity and Transplantation, University College London, London, United Kingdom.
Ondrej SuchanekMolecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom.
Peter ThomasDivision of Infection and Immunity, Institute for Immunity and Transplantation, University College London, London, United Kingdom.
Sarah A GriffithDivision of Infection and Immunity, Institute for Immunity and Transplantation, University College London, London, United Kingdom.
Emma TouizerDivision of Infection and Immunity, Institute for Immunity and Transplantation, University College London, London, United Kingdom.
Chloe Rees-SpearDivision of Infection and Immunity, Institute for Immunity and Transplantation, University College London, London, United Kingdom.
Robert KrauseAfrica Health Research Institute, Durban, South Africa.
Masahiro YoshidaUCL Respiratory, Division of Medicine, University College London, London, United Kingdom.
Christopher L PinderDivision of Infection and Immunity, Institute for Immunity and Transplantation, University College London, London, United Kingdom.
Rutuja PatilDivision of Infection and Immunity, Institute for Immunity and Transplantation, University College London, London, United Kingdom.
Marko Z NikolicUCL Respiratory, Division of Medicine, University College London, London, United Kingdom.
Katie J DooresDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.
Marit J Van GilsDepartment of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Alasdair LeslieDivision of Infection and Immunity, Institute for Immunity and Transplantation, University College London, London, United Kingdom.
Alex SigalAfrica Health Research Institute, Durban, South Africa.
Ravindra K GuptaCambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, United Kingdom.
Menna R ClatworthyMolecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom.
Laura E McCoyDivision of Infection and Immunity, Institute for Immunity and Transplantation, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0001-9503-7946

Funding

Gates Foundation INV-018944Wellcome Trust
6 · The paper itself

Abstract

Chronic HIV infection drives B cell dysfunction associated with the accumulation of tissue-like memory (TLMs) and activated memory B cells (MBCs) but decline in resting memory B cells. TLMs express multiple inhibitory receptors and lack response to soluble antigens. However, their origin and the mechanisms driving their expansion in HIV infection remain unclear. From bulk heavy chain BCR sequencing of MBC subsets from 5 PLWH with no detectable viremia, we hypothesized that TLMs (CD21- CD27- B cells) were significantly less mutated but also less diverse than other MBCs, suggesting an enrichment for innate-like B cells or that they belong to a less mature subset. Subsequent detailed multi-omics study of an immune response to a transient HIV viremia in an elite controller demonstrated a functional increase in Env-reactive IgG and MBCs with non-TLM phenotype. Single-cell RNA/BCR sequencing of PBMCs enriched for B cells revealed an orchestrated TNF-α response followed by interferon-α and -γ responses across all B cell subsets. This study provides new insights into multifaceted functional B cell response to transient HIV viremia and highlights TLM heterogeneity.

Indexed as

B-LymphocytesHIV-1HIV InfectionsMemory B CellsViremiaHumansImmunologic Memory

Identifiers

PMID41544177
PMCPMC12890225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.